Datroway (datopotamab deruxtecan-dlnk) is a treatment for adult patients with unresectable or metastatic HR-positive, HER2-negative breast cancer who have previously ... With these approvals, ...

AstraZeneca and Daiichi Sankyo withdrew an application in the European Union for the drug to treat a type of lung cancer in December following feedback from regulatory advisers. Mixed results from ...

AstraZeneca and Daiichi's first co-developed ADC, Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions. In December ...

Two AstraZeneca (AZ) drugs have been approved in Japan – its cancer drug Lynparza and its respiratory drug Fasenra. The Japanese Ministry of Health, Labour and Welfare approved Lynparza ...

The UAB Department of Radiation Oncology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...

AstraZeneca CFO Aradhana Sarin promised Phase III readouts and revenue growth in 2025 despite ongoing investigations of its Chinese operations. Credit: Bloomberg/ Getty Images AstraZeneca says a ...

Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca, said ... whose disease has become resistant to current treatments.” Ken Takeshita, MD, Global Head, R&D, Daiichi Sankyo, said, ...

These make five multifamily deals north of $100M we've reported on in just the last few weeks. Sentinel Real Estate Corp. recently bought two big apartment communities in Tysons and Gaithersburg ...

Copies of AstraZeneca Plc’s Calquence tablets proposed by MSN Laboratories Pvt. Ltd. infringe two patents for the blood-cancer treatment, according to a federal lawsuit filed six months after MSN ...

AstraZeneca’s business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases, vaccines and other.